Topics

Adult-type Diffuse Gliomas | Treatment | Clinical trials | Temozolomide

Home > Publications > Topics > Adult-type Diffuse Gliomas > Treatment > Clinical trials > Temozolomide

Zhang J, Wang P, Ren Y, Chen L, Feng J, Liu F, Deng K, Bao Z, Qiu X, Liu Y.
Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild-type and TERT promoter mutation histological grade 2/3 gliomas: An extension retrospective analysis of a randomized controlled trial.
Cancer. 2025 Dec 1;131(23):e70171. doi: 10.1002/cncr.70171. PMID: 41328764. Interventional study. ˍ